Two recent approvals reduce patient ‘drop burden’ after cataract surgery

WAIKOLOA, Hawaii — The current post-cataract surgery drop regimen puts “significant burden on patients” and often leads to poor outcomes, high patient call volume and patient satisfaction, according to a speaker here.
Patients receive a steroid, an antibiotic and an NSAID and represent “over 105 drops in a 4-week period,” Cynthia A. Matossian, MD, FACS, said here at Hawaiian Eye 2019. “And 93% of patients improperly administer drops following cataract surgery.”
Some recent FDA approvals may reverse this trend, she said. And steps have been taken for

Full Story →